GlassScriptPhysician profile
Steven Pliskow
NPI 1659418614
$1,435.78
in general payments reported to CMS, 2019-2025
23 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $72.52 · 2021: $85.40 · 2022: $160 · 2023: $312 · 2024: $260 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $904.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $425.79 | 2023-2025 | |
| Abbvie INC. | $132.06 | 2019-2022 | |
| Exeltis, USA INC. | $87.91 | 2022-2025 | Slynd |
| Coopersurgical, INC. | $85.26 | 2020-2023 | Summit Doppler |
| Therapeuticsmd, INC. | $77.23 | 2019-2022 | |
| Organon LLC | $65.06 | 2023-2024 | Nexplanon |
| Hologic Sales and Service, LLC | $63.26 | 2020-2025 | Fluent Fluid Management System, Thinprep 2000 Processor, Aptima |
| Evofem Biosciences, INC. | $54.61 | 2021 | |
| Pfizer INC. | $50.76 | 2021-2023 | |
| Mylan Pharmaceuticals INC. | $48.46 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $44.45 | 2023 | Seglentis |
| Millicent US INC | $42.74 | 2025 | Femlyv, Intrarosa |
| Channel Medsystems, INC. | $37.93 | 2023 | |
| Minerva Surgical, INC | $33.06 | 2019 | |
| Allergan, INC. | $30.86 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $28.18 | 2024 | Twirla |
| Vertex Pharmaceuticals Incorporated | $24.64 | 2025 | |
| Exact Sciences Corporation | $22.50 | 2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $19.06 | 2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $17.69 | 2025 | |
| Ethicon US, LLC | $16.59 | 2024 | Ethicon, Vistaseal |
| Avion Pharmaceuticals | $15.61 | 2023 | Balcoltra |
| Daiichi Sankyo INC. | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Pliskow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.